Zeena Marshall
Psychiatry · Bronxville, NYNPI 1609827575
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 271 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 30.8% of the total. Reporting peaked in 2021 at $1,946 and has fallen 88.6% since, to $222 in 2025. Among psychiatry clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 271 payments — averaging $17.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$558
- Lundbeck LLC$481
- Sunovion Pharmaceuticals Inc.$401
- Alkermes, Inc.$364
- Johnson & Johnson$291
- plus $1K from 15 others
What the payments were for
- Food & beverage$4,811100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 114 | $1,484 |
| Otsuka America Pharmaceutical, Inc. | 26 | $558 |
| Lundbeck LLC | 27 | $481 |
| Sunovion Pharmaceuticals Inc. | 26 | $401 |
| Alkermes, Inc. | 10 | $364 |
| Johnson & Johnson | 10 | $291 |
| Bausch Health US, LLC | 14 | $267 |
| Adlon Therapeutics L.p. | 10 | $167 |
| Vanda Pharmaceuticals Inc. | 1 | $126 |
| Tris Pharma Inc | 7 | $115 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $88 |
| Neuronetics, Inc. | 2 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $75 |
| Ironshore Pharmaceuticals Inc. | 4 | $66 |
| Supernus Pharmaceuticals, Inc. | 3 | $62 |
| Validus Pharmaceuticals LLC | 3 | $54 |
| Shire North American Group Inc | 2 | $34 |
| Arbor Pharmaceuticals, Inc. | 2 | $33 |
| Neurocrine Biosciences, Inc. | 1 | $27 |
| Eisai Inc. | 1 | $17 |
| Vertical Pharmaceuticals, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$500
- Fanapt$126
- ABILIFY MAINTENA$125
- ARISTADA INITIO$125
- SPRAVATO$124
How this compares
$4,811 in reported general payments places this provider in the 90th percentile of 3,713 psychiatry providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clozapine | 24 | $1,545 |
| Olanzapine | 22 | $147 |
| Risperidone | 11 | $72 |
| Escitalopram Oxalate | 14 | $42 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Bronxville
- Leslie CitromePomona$5.7M
- Sanjay GuptaCheektowaga$1.9M
- Richard PriceMonsey$1.7M
- Adam AshtonAmherst$1.6M
- Christoph CorrellGlen Oaks$1.5M
- Manish ZinzuvadiaNew York$1.3M
- George KruseBronx$1.2M
- Jianping ChenNew York$1.2M
- Horacio CapoteAmherst$1.1M
- Yadagiri ChepuruYonkers$963K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.